<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/sitemap.xsl"?>
<!--
  =====================================================================
  sitemap.xml — amyloidosissupport.in
  Generated: May 2026
  
  HOW TO USE:
  1. Upload this file to your WordPress root directory:
     /public_html/sitemap.xml
  2. Submit to Google Search Console:
     GSC → Sitemaps → Add new sitemap → enter "sitemap.xml"
  3. Submit to Bing Webmaster Tools similarly
  4. Add to robots.txt (already configured)
  
  UPDATE POLICY:
  - Add new content within 24 hours of publishing
  - Update <lastmod> whenever you edit a page
  - Priority scale: 1.0 = most important, 0.1 = least
  - Changefreq: always/hourly/daily/weekly/monthly/yearly/never
  =====================================================================
-->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:xhtml="http://www.w3.org/1999/xhtml"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">

  <!-- ═══════════════════════════════════
       CORE PAGES
       ═══════════════════════════════════ -->

  <url>
    <loc>https://amyloidosissupport.in/</loc>
    <lastmod>2026-05-09</lastmod>
    <changefreq>weekly</changefreq>
    <priority>1.0</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/amyloidosis-center/</loc>
    <lastmod>2026-05-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.9</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/understanding-amyloidosis</loc>
    <lastmod>2026-05-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.9</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/</loc>
    <lastmod>2026-05-09</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.9</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/our-team/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/contact/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.6</priority>
  </url>

  <!-- ═══════════════════════════════════
       KNOWLEDGE BASE — CHAPTERS
       IDs from MongoDB (_id field)
       URL pattern: /knowledge-base/chapter/:id
       ═══════════════════════════════════ -->

  <!-- Chapter 1: Introduction: The Case for Rare Disease Classification -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787a8fd4f477a58b70aa</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter 2: Understanding Amyloidosis: Cellular to Systemic -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787a8fd4f477a58b70ae</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter 3: Rare Diseases and the NPRD 2021 Framework -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787a8fd4f477a58b70b2</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter 4: Collateral Damages of Non-Recognition -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787b8fd4f477a58b70b6</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter 5: Methodology: Evidence-Based Advocacy -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787b8fd4f477a58b70ba</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- Chapter 6: Results: The Burden of the Undiagnosed -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787b8fd4f477a58b70be</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter 7: Discussion: Aligning with International Guidelines -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787b8fd4f477a58b70c2</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- Chapter 8: Conclusion: A Call to Action for Policy Change -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787b8fd4f477a58b70c6</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- Chapter 10: GI Complications and Medication Safety -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787d8fd4f477a58b70ce</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- Chapter 11: Amyloidology: 51 Questions & Answers -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db787e8fd4f477a58b70d2</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter 12: Therapeutic Solutions: Chemotherapy to Gene Editing -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db78808fd4f477a58b70d6</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter 13: Systemic vs. Localised Amyloidosis -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69db78818fd4f477a58b70da</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter: Bone Marrow Aspiration, Biopsy & Diagnostic Tests in AL Amyloidosis -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69f44f5d9cb77aa1eec4991e</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- Chapter: Understanding Advanced Clinical Approaches in Amyloidosis -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69f77d7379f89cdb39a25b7c</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <!-- Chapter: Emerging Innovations and Treatment Strategies in Amyloidosis -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69f77dee79f89cdb39a25b82</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <!-- Chapter: Advances in Diagnosis and Clinical Management of Amyloidosis -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69f77eaa79f89cdb39a25b88</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <!-- Chapter: Clinical Insights and Treatment Approaches in Amyloidosis -->
  <url>
    <loc>https://amyloidosissupport.in/knowledge-base/chapter/69f77f2f79f89cdb39a25b8e</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <!-- ═══════════════════════════════════
       51 QUESTIONS SERIES
       URL pattern: /51-questions-series/:id
       ═══════════════════════════════════ -->

  <!-- 51 Q: Essential Questions & Answers on Amyloidosis (Part 1) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db78018fd4f477a58b7093</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- 51 Q: GI Amyloidosis (Part 2) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db79018fd4f477a58b7131</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 51 Q: National Health Policy (Part 3) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db7a8a8fd4f477a58b7282</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 51 Q: Clinical Features of Amyloidosis (Part 4) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db7c558fd4f477a58b72c6</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 51 Q: Comprehensive Knowledge Resource (Part 5) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db7d8d8fd4f477a58b72d8</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 51 Q: Relapsed Cardiac AL Amyloidosis (Part 6) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db7e0b8fd4f477a58b72de</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 51 Q: Awareness & Education (Part 7) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db7e758fd4f477a58b72e4</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 51 Q: Community — Mental health, research, and advocacy (Part 8) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69db7eec8fd4f477a58b72ea</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 51 Q: Progressive Clinical Innovations (Part 33) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69f78a7579f89cdb39a25baa</loc>
    <lastmod>2026-05-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <!-- 51 Q: Advanced Clinical Insights and Emerging Innovations (Part 34) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69f78d0a79f89cdb39a25bb0</loc>
    <lastmod>2026-05-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <!-- 51 Q: Advanced Clinical Progress and Future Innovations (Part 35) -->
  <url>
    <loc>https://amyloidosissupport.in/51-questions-series/69f78dc079f89cdb39a25bb6</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <!-- ═══════════════════════════════════
       101 QUESTIONS SERIES
       URL pattern: /101-questions-series/:id
       ═══════════════════════════════════ -->

  <!-- 101 Q: Understanding Plasma Cells & AL Amyloidosis (Part 1) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69db6bba7ab9e37b69d386e4</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- 101 Q: Interpreting GLS & Cardiac Amyloidosis (Part 2) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69db6ef38fd4f477a58b6e92</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- 101 Q: The Indian Amyloidosis Journey & Radical Hope (Part 3) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69db72008fd4f477a58b6f47</loc>
    <lastmod>2026-05-05</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- 101 Q: Essential Q&A — Patient & Caregiver Guide (Part 1 new) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69facdf579f89cdb39a26066</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- 101 Q: Diagnosis, Testing & Medical Evaluation (Part 2) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69facf6b79f89cdb39a2606e</loc>
    <lastmod>2026-05-07</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- 101 Q: Treatment Options & Clinical Management (Part 3) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69fb985379f89cdb39a26170</loc>
    <lastmod>2026-05-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- 101 Q: Advanced Care, Complications & Support Systems (Part 4) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69fb7cfd79f89cdb39a26108</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 101 Q: Research, Future Therapies & Patient Empowerment (Part 5) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69fb7e1f79f89cdb39a2610e</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 101 Q: Awareness, Prevention & Patient Resources (Part 6) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69fb97bd79f89cdb39a2616a</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 101 Q: Patient Stories, FAQs & Final Insights (Part 8) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69fb96b079f89cdb39a26160</loc>
    <lastmod>2026-05-06</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.80</priority>
  </url>

  <!-- 101 Q: Dissecting the Truth — For 1.4 Billion Indians (Part 10) -->
  <url>
    <loc>https://amyloidosissupport.in/101-questions-series/69fe0a4f79f89cdb39a261f1</loc>
    <lastmod>2026-05-08</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.85</priority>
  </url>

  <!-- ═══════════════════════════════════
       BLOG / ARTICLES
       ═══════════════════════════════════ -->

  <url>
    <loc>https://amyloidosissupport.in/primary-al-amyloidosis-vs-other-amyloidosis/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/types-of-amyloidosis/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/chronic-inflammation-cause-aa-amyloidosis/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/tlr4-nf-%CE%BAb-pathway-contribute/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.65</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/light-chain-multiple-myeloma/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.75</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/fluid-balance-in-amyloidosis-why-too-much/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.70</priority>
  </url>

  <url>
    <loc>https://amyloidosissupport.in/amyloidosis-the-silent-disease-we-need/</loc>
    <lastmod>2026-04-01</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.70</priority>
  </url>

</urlset>